PRECISION BIOSCIENCES INC Contracts & Agreements
83 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (5)
- Human Resources (30)
- Intellectual Property (9)
- Real Estate (10)
- Uncategorized (5)
- PRECISION BIOSCIENCES, INC. AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on November 4, 2024)
- EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 4, 2024)
- Consulting Agreement between Precision BioSciences, Inc. and Dr. Alan List, dated September 13, 2024 (Filed With SEC on November 4, 2024)
- Amended and Restated Loan and Security Agreement, entered into as of July 31, 2024, by and between Banc of California and Precision BioSciences, Inc (Filed With SEC on August 1, 2024)
- Eighth Amendment to Loan and Security Agreement, entered into as of June 21, 2024, by and between Banc of California (f/k/a Pacific Western Bank) and Precision BioSciences, Inc (Filed With SEC on August 1, 2024)
- Precision BioSciences, Inc. 2019 Incentive Award Plan, as Amended and Restated (Filed With SEC on June 10, 2024)
- License Agreement by and among TG Therapeutics, Inc., TG Cell Therapy, Inc. and Precision BioSciences, Inc (Filed With SEC on March 27, 2024)
- Description of Registrants Securities (Filed With SEC on March 27, 2024)
- Underwriting Agreement, dated March 1, 2024, between the Company and Guggenheim Securities, LLC (Filed With SEC on March 1, 2024)
- Form of Warrant (Filed With SEC on March 1, 2024)
- Executive EMPLOYMENT AGREEMENT (Filed With SEC on January 23, 2024)
- Executive EMPLOYMENT AGREEMENT (Filed With SEC on January 23, 2024)
- Executive EMPLOYMENT AGREEMENT (Filed With SEC on January 23, 2024)
- Executive Employment Agreement, dated January 22, 2024, by and between Michael Amoroso and Precision BioSciences, Inc (Filed With SEC on January 23, 2024)
- Tenth Amendment to Lease Agreement between Precision BioSciences, Inc. and Venable Historic, LLC, successor-in-interest to Venable Tenant, LLC, dated October 16, 2023 (Filed With SEC on November 7, 2023)
- License Agreement, effective as of August 15, 2023 by and between Precision BioSciences, Inc. and Imugene (USA) Inc (Filed With SEC on August 21, 2023)
- Asset Purchase Agreement, dated as of August 15, 2023, by and among Precision BioSciences, Inc., Imugene (USA) Inc. and Imugene Limited (Filed With SEC on August 21, 2023)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Dr. Alan List, dated November 7, 2022 (Filed With SEC on November 8, 2022)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Alex Kelly, dated November 7, 2022 (Filed With SEC on November 8, 2022)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Dario Scimeca, dated November 7, 2022 (Filed With SEC on November 8, 2022)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Dr. Derek Jantz, dated November 7, 2022 (Filed With SEC on November 8, 2022)
- Employment Agreement between Precision BioSciences, Inc. and Dr. J. Jefferson Smith, dated November 7, 2022 (Filed With SEC on November 8, 2022)
- Seventh Amendment to Loan and Security Agreement, entered into as of May 27, 2022, by and among Pacific Western Bank, Precision BioSciences, Inc., and Precision PlantSciences,... (Filed With SEC on August 8, 2022)
- NonEmployee Director Compensation Plan (as amended) (Filed With SEC on August 8, 2022)
- Underwriting Agreement, dated June 21, 2022, between the Company and Jefferies LLC (Filed With SEC on June 22, 2022)
- Registration Rights Agreement, dated June 15, 2022, by and between Precision BioSciences, Inc. and Novartis Pharma AG (Filed With SEC on June 21, 2022)
- Stock Purchase Agreement, dated June 14, 2022, by and between Precision BioSciences, Inc. and Novartis Pharma AG (Filed With SEC on June 21, 2022)
- Collaboration and License Agreement, dated June 14, 2022, by and between Precision BioSciences, Inc. and Novartis Pharma AG (Filed With SEC on June 21, 2022)
- Lease Agreement between Precision BioSciences, Inc. and Durham TW Alexander, LLC, dated October 2, 2018, as amended (Filed With SEC on March 15, 2022)
- Description of the Registrant's Securities (Filed With SEC on March 15, 2022)
- Loan and Security Agreement, dated May 15, 2019, among Precision BioSciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank, as amended (Filed With SEC on March 15, 2022)
- Consulting Agreement between Precision BioSciences, Inc. and Dr. David Thomson, dated July 2, 2021 (Filed With SEC on November 10, 2021)
- First Amendment to Development and License Agreement between Eli Lilly and Company and Precision BioSciences, Inc., dated August 9, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement, dated September 18, 2021, by and between Michael Amoroso and Precision Biosciences, Inc (Filed With SEC on September 27, 2021)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Alex Kelly, dated May 27, 2021 (Filed With SEC on August 12, 2021)
- Amended and Restated Employment Agreement between Precision BioSciences, Inc. and Alex Kelly, dated May 27, 2021 (Filed With SEC on May 27, 2021)
- Program Purchase Agreement by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier and Precision BioSciences, Inc., dated April 9, 2021 (Filed With SEC on May 13, 2021)
- Employment Agreement between Precision BioSciences, Inc. and Alan List, dated April 26, 2021 (Filed With SEC on May 13, 2021)
- Consulting Agreement between Precision BioSciences, Inc. and Christopher Heery, M.D., dated April 23, 2021 (Filed With SEC on May 13, 2021)
- Non-Employee Director Compensation Plan (as amended) (Filed With SEC on May 13, 2021)
- Fourth Amendment to Lease, dated May 4, 2021, to Lease Agreement between Precision BioSciences, Inc. and Durham TW Alexander, LLC, dated October 2, 2018, as amended (Filed With SEC on May 13, 2021)
- Transition and Separation Agreement between Precision BioSciences, Inc. and Matthew Kane, dated April 5, 2021 (Filed With SEC on April 6, 2021)
- Stock Purchase Agreement between Eli Lilly and Company and Precision BioSciences, Inc., dated November 19, 2020 (Filed With SEC on March 18, 2021)
- Development and License Agreement between Eli Lilly and Company and Precision BioSciences, Inc., dated November 19, 2020 (Filed With SEC on March 18, 2021)
- Loan and Security Agreement, dated May 15, 2019, among Precision BioSciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank, as amended (Filed With SEC on March 18, 2021)
- Description of the Registrant's Securities (Filed With SEC on March 18, 2021)
- Amendment No. 6, dated October 16, 2020, to Development and Commercial License Agreement by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier... (Filed With SEC on November 10, 2020)
- Ninth Amendment to Lease, dated August 31, 2020, to Lease Agreement between Precision BioSciences, Inc. and Venable Historic, LLC dated April 5, 2010, as amended (Filed With SEC on November 10, 2020)
- Third Amendment to Lease, dated June 15, 2020, to Lease Agreement between Precision BioSciences, Inc. and Durham TW Alexander, LLC, dated October 2, 2018, as amended (Filed With SEC on August 13, 2020)
- Third Amendment to the Loan and Security Agreement, dated June 23, 2020, among Precision BioSciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank (Filed With SEC on June 26, 2020)
- Eighth Amendment, dated March 3, 2020, to Lease Agreement between Precision BioSciences, Inc. and Venable Tenant, LLC, dated April 5, 2010, as amended (Filed With SEC on May 15, 2020)
- Second Amendment to Lease, dated March 12, 2020, to Lease Agreement between Precision BioSciences, Inc. and Durham TW Alexander, LLC, dated October 2, 2018, as amended (Filed With SEC on May 15, 2020)
- Amendment No. 1, dated March 10, 2020, to Collaboration and License Agreement by and between Gilead Sciences, Inc. and Precision BioSciences, Inc., dated September 10, 2018, as... (Filed With SEC on May 15, 2020)
- Description of the Registrant's Securities (Filed With SEC on March 10, 2020)
- Second Amendment, dated December 3, 2019, to Loan and Security Agreement, dated May 15, 2019, among Precision BioSciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank (Filed With SEC on March 10, 2020)
- Amendment No. 2 to the Amended and Restated Investors Rights Agreement among the Company and certain of its stockholders and the holders of the 2019 Notes, dated May 25, 2018, as... (Filed With SEC on February 6, 2020)
- Amendment No. 5, dated October 23, 2019, to Development and Commercial License Agreement by and between Les Laboratoires Servier and Precision BioSciences, Inc., dated February... (Filed With SEC on November 12, 2019)
- First Amendment, dated September 13, 2019, to Loan and Security Agreement, dated May 15, 2019, among Precision Biosciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank (Filed With SEC on November 12, 2019)
- Loan and Security Agreement, dated May 15, 2019, among Precision BioSciences, Inc., Elo Life Systems, Inc. and Pacific Western Bank (Filed With SEC on May 20, 2019)
- 2019 Incentive Award Plan, and form of award agreements thereunder (Filed With SEC on April 29, 2019)
- Employment Agreement between the Registrant and David Thomson, dated February 27, 2019 (Filed With SEC on March 18, 2019)
- Employment Agreement between the Registrant and Fayaz Khazi, dated February 27, 2019 (Filed With SEC on March 18, 2019)
- Form of Indemnification Agreement between the Registrant and its directors and officers (Filed With SEC on March 18, 2019)
- Non-Employee Director Compensation Plan (Filed With SEC on March 18, 2019)
- Employment Agreement between the Registrant and Abid Ansari, dated February 27, 2019 (Filed With SEC on March 18, 2019)
- Employment Agreement between the Registrant and Derek Jantz, dated February 27, 2019 (Filed With SEC on March 18, 2019)
- Employment Agreement between the Registrant and Matthew Kane, dated February 27, 2019 (Filed With SEC on March 18, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on March 18, 2019)
- 2019 Incentive Award Plan, and form of award agreements thereunder (Filed With SEC on March 18, 2019)
- Form of Underwriting Agreement (Filed With SEC on March 18, 2019)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders and the holders of the 2019 Notes, dated May 25, 2018, as amended (Filed With SEC on March 18, 2019)
- Lease Agreement between the Registrant and VC Owner, dated April 5, 2010, as amended (Filed With SEC on March 18, 2019)
- Specimen Common Stock Certificate (Filed With SEC on March 18, 2019)
- Development and Commercial License Agreement by and between Les Laboratoires Servier and the Registrant, dated February 24, 2016, as amended (Filed With SEC on March 13, 2019)
- Collaboration and License Agreement by and between Gilead Sciences, Inc. and the Registrant, dated September 10, 2018 (Filed With SEC on March 13, 2019)
- Lease Agreement between Elo Life Systems, Inc. and ARE-NC Region No. 17, LLC, dated March 29, 2018, as amended (Filed With SEC on March 1, 2019)
- License Agreement by and between Duke University and the Registrant, dated April 17, 2006, as amended (Filed With SEC on March 1, 2019)
- Patent Cross-License Agreement by and between Cellectis SA and the Registrant, dated January 23, 2014 (Filed With SEC on March 1, 2019)
- Collaboration and License Agreement by and between Gilead Sciences, Inc. and the Registrant, dated September 10, 2018 (Filed With SEC on March 1, 2019)
- 2006 Stock Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on March 1, 2019)
- 2015 Stock Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on March 1, 2019)
- Lease Agreement between Registrant and Durham TW Alexander, LLC, dated October 2, 2018 (Filed With SEC on March 1, 2019)
- Development and Commercial License Agreement by and between Les Laboratoires Servier and the Registrant, dated February 24, 2016, as amended (Filed With SEC on March 1, 2019)